<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39391113</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2000-9666</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of community hospital internal medicine perspectives</Title><ISOAbbreviation>J Community Hosp Intern Med Perspect</ISOAbbreviation></Journal><ArticleTitle>IgA Nephropathy Secondary to COVID-19 Infection - A Case Report.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>56</EndPage><MedlinePgn>53-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.55729/2000-9666.1370</ELocationID><Abstract><AbstractText>We present a case of a 73-year-old African American lady with COVID-19 infection who developed acute Kidney Injury (AKI) and significant proteinuria. Renal biopsy showed IgA nephropathy. Patient was eventually diagnosed with IgA nephropathy secondary to COVID Infection. This unique case highlights the complexity of renal involvement in COVID-19. Notably, the onset of IgA nephropathy in the patient occurred several weeks after her COVID-19 diagnosis, deviating from the typical synpharyngitic presentation. This article contributes to the growing body of evidence regarding renal complications associated with COVID-19 and highlights the need for vigilance in assessing and managing renal conditions in COVID-19 patients, especially when atypical presentations occur.</AbstractText><CopyrightInformation>© 2024 Greater Baltimore Medical Center.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Sanjivani</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandaru</LastName><ForeName>Sumanth K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, MedStar Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michael Siu</LastName><ForeName>Man K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Nephrology, University of California, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malvica</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabacar</LastName><ForeName>Joselito</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Washington Nephrology, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Community Hosp Intern Med Perspect</MedlineTA><NlmUniqueID>101601396</NlmUniqueID><ISSNLinking>2000-9666</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID nephropathy</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">FSGS</Keyword><Keyword MajorTopicYN="N">Focal segmental glomerulosclerosis</Keyword><Keyword MajorTopicYN="N">IgA nephropathy</Keyword><Keyword MajorTopicYN="N">Renal</Keyword></KeywordList><CoiStatement>Conflicts of interest: Authors have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391113</ArticleId><ArticleId IdType="pmc">PMC11464053</ArticleId><ArticleId IdType="doi">10.55729/2000-9666.1370</ArticleId><ArticleId IdType="pii">jchim-14-04-053</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sabaghian T, Kharazmi AB, Ansari A, et al. COVID-19 and acute kidney injury: a systematic review. Front Med. 2022 Apr 4;9:705908. doi: 10.3389/fmed.2022.705908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.705908</ArticleId><ArticleId IdType="pmc">PMC9014846</ArticleId><ArticleId IdType="pubmed">35445048</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir A, Walia J, Daly T, Gradzka A, Banai R. Rapidly progressive glomerulonephritis: a COVID-19 case report. Cureus. 2023 Apr 18;15(4):e37767. doi: 10.7759/cureus.37767.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.37767</ArticleId><ArticleId IdType="pmc">PMC10194189</ArticleId><ArticleId IdType="pubmed">37214004</ArticleId></ArticleIdList></Reference><Reference><Citation>Batlle D, Soler MJ, Sparks MA, et al. COVID-19 and ACE2 in cardiovascular, lung, and kidney working group. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020 Jul;31(7):1380–1383. doi: 10.1681/ASN.2020040419. . Epub 2020 May 4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020040419</ArticleId><ArticleId IdType="pmc">PMC7350999</ArticleId><ArticleId IdType="pubmed">32366514</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection. Infectious Diseases (except HIV/AIDS) 2020</Citation></Reference><Reference><Citation>Fan C, Lu W, Li K, Ding Y, Wang J. Ace2 expression in kidney and testis may cause kidney and testis infection in covid-19 patients. Front Med. 2021;7:563893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7838217</ArticleId><ArticleId IdType="pubmed">33521006</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzedine H, Jhaveri KD. Acute kidney injury in patients with COVID-19: an update on pathophysiology. Nephrol Dial Transplant. 2021;36(2):224–226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499744</ArticleId><ArticleId IdType="pubmed">32888298</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Li XJ, Li YQ, et al. Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report. BMC Nephrol. 2020;21(1):504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685298</ArticleId><ArticleId IdType="pubmed">33234164</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutiérrez E, Carvaca-Fontán F, Luzardo L, Morales E, Alonso M, Praga M. A personalized update on iga nephropathy: a new vision and new future challenges. Nephron. 2020;144(11):555–571.</Citation><ArticleIdList><ArticleId IdType="pubmed">32818944</ArticleId></ArticleIdList></Reference><Reference><Citation>Suso AS, Mon C, Oñate Alonso I, et al. Iga vasculitis with nephritis (Henoch–schönlein purpura) in a covid-19 patient. Kidney Int Rep. 2020;5(11):2074–2078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439008</ArticleId><ArticleId IdType="pubmed">32839743</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour SJ, Coppo R, Zhang H, et al. International IgA Nephropathy Network. Evaluating a new international risk-prediction Tool in IgA nephropathy. JAMA Intern Med. 2019 Jul 1;179(7):942–952. doi: 10.1001/jamainternmed.2019.0600. . Erratum in: JAMA Intern Med 2019 Jul 1; 179(7)1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2019.0600</ArticleId><ArticleId IdType="pmc">PMC6583088</ArticleId><ArticleId IdType="pubmed">30980653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4S):S1–S276. doi: 10.1016/j.kint.2021.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.05.021</ArticleId><ArticleId IdType="pubmed">34556256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>